Skip to main content
Funded Studies

Malú G. Tansey, PhD

Professor of Neuroscience at University of Florida

Location: Gainesville, FL United States

Malú Gámez Tansey, PhD, earned her BS/MS from Stanford University and her PhD from University of Texas Southwestern and did postdoctoral work at Washington University on GDNF/Ret signaling. She spent two years at Xencor, where she co-invented dominant-negative soluble TNF inhibitors currently in clinical trials for Alzheimer’s disease and COVID-19. Today, she is the Norman and Susan Fixel Chair in Neuroscience and Neurology and Co-Director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida College of Medicine in Gainesville. Her lab focuses on the role of inflammation and immune system responses in brain health and mechanisms underlying development of neurodegenerative diseases. The long-term goal of her laboratory is to enable earlier diagnoses and better therapies to prevent and/or delay these diseases. Dr. Tansey is a fierce advocate for women and other under-represented groups in STEM and has earned several mentoring awards from students and faculty for these efforts.


Associated Grants

  • Targeting LRRK2 in Models of Gastrointestinal Inflammation

    2019


  • URMC-099 in an In Vivo AAV-hSYN Model of Parkinson’s Disease

    2018


  • Assessing Proteins LRRK2, GCase and Cytokines in Immune Cells

    2018


  • Defining a Parkinson's Disease-specific Breath Fingerprint of Inflammatory and Neurodegenerative Processes

    2016


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.